Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Nicolas Loof

1PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 31, 2021
CD11c<sup>+</sup>CD88<sup>+</sup>CD317<sup>+</sup> myeloid cells are critical mediators of persistent CNS autoimmunity.

Navid Manouchehri, Rehana Z Hussain, Petra D Cravens

Pageof 1

Frequent Collaborators

1 joint publications

Navid Manouchehri

1 joint publications

Rehana Z Hussain

1 joint publications

Brian T Edelson

1 joint publications

Gregory F Wu

1 joint publications

Anne H Cross

1 joint publications

Thomas G Forsthuber

1 joint publications

Laurent Calvier

1 joint publications

Olaf Stüve

Frequent Collaborators

1 joint publications

Navid Manouchehri

1 joint publications

Rehana Z Hussain

1 joint publications

Brian T Edelson

1 joint publications

Gregory F Wu

Top Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.5K
See more related videos

Top Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.5K
See more related videos